| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Barinthus Biotherapeutics Plc. (BRNS) has 0 insiders with recent SEC Form 4 filings, including 8 buys and 2 sells. BRNS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 28, 2022 | Ellis Christopher75 | Chief Operating Officer | Sale+OE | 5 | $6.00 | $30.00 | -6.3% | -41.5% | -57.1% | |
| Jun 23, 2022 | Griffiths Graham68 | Chief Business Officer | Sale+OE | 8 | $5.28 | $42.24 | - | -37.8% | -57.8% | |
| Apr 1, 2022 | Scheeren Joseph | Director | Buy | 10,000 | $5.09 | $50,900.00 | +333.3% | -14.3% | -56.8% | |
| Mar 31, 2022 | Hammacher Alex | Director | Buy | 2,000 | $5.14 | $10,280.00 | +200.0% | -1.7% | -56.9% | |
| Dec 31, 2021 | Hammacher Alex | Director | Buy | 1,000 | $10.86 | $10,860.00 | New | -53.2% | -78.8% | |
| Dec 22, 2021 | Wright Robin | Director | Buy | 10,000 | $9.97 | $99,700.00 | +40.8% | -41.8% | -73.8% | |
| May 4, 2021 | Oxford Sciences Innovation Plc | 10% Owner | Buy | 600,000 | $17.00 | $10,200,000.00 | +7.3% | +14.1% | -62.1% | |
| May 4, 2021 | Griffiths Graham68 | Chief Business Officer | Buy | 100 | $17.00 | $1,700.00 | New | +14.1% | -62.1% | |
| May 4, 2021 | Ellis Christopher75 | Chief Operating Officer | Buy | 75 | $17.00 | $1,275.00 | New | +14.1% | -62.1% | |
| May 4, 2021 | Phillips Anne M. | Director | Buy | 3,000 | $17.00 | $51,000.00 | New | +14.1% | -62.1% |